| Nov 19 |
NVRO Stock Declines Despite Positive Study Data of Nevro1 System
|
| Nov 18 |
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
|
| Nov 5 |
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
|
| Nov 1 |
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade
|
| Oct 30 |
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
|
| Oct 29 |
Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three years
|
| Oct 29 |
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?
|
| Oct 24 |
AngioDynamics launches long-term study of NanoKnife for prostate cancer
|
| Oct 23 |
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE
|
| Oct 23 |
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
|
